Imaging and Pathological Features of Idiopathic Portal Hypertension and Differential Diagnosis from Liver Cirrhosis

Zhen-Long Zhao,Ying Wei,Tai-Ling Wang,Li-Li Peng,Yan Li,Ming-An Yu

DOI: https://doi.org/10.1038/s41598-020-59286-8

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

What problem does this paper attempt to address?

Treatment Options for Portal Hypertension in the Era of Liver Transplantation

Xu Xiao,Guo Haijun,Li Wangyao

DOI: https://doi.org/10.3760/cma.j.issn.1673-9752.2018.10.005

2018-01-01

Abstract:Liver transplantation makes it possible to cure portal hypertension thoroughly.A new pattern of combined application of multiple treatments based on liver transplantation has emerged.Conventional surgical treatments such as splenectomy,devascularization and transjugular intrahepatic portosystemic shunting have important effects on the prognosis of liver transplant recipients.Portal vein stenosis,thrombosis as well as small-for-size liver graft lead to post-transplant portal hypertension and liver dysfunction.The author in this article provides an overview of the effects of various conventional treatments on the prognosis of recipients and the treatment of portal hypertension after liver transplantation,aiming to seek for optimal strategy.
Liver Pathology in Idiopathic Portal Hypertension

Xia Liu,Tai-ling Wang,Can-hong Xiang,Xiang-xin Peng,Yue Wang,Nian Chen,Min Zhang

DOI: https://doi.org/10.3760/j.issn:1007-3418.2007.05.015

2007-01-01

Abstract:OBJECTIVE:To study the histopathological changes of livers in idiopathic portal hypertension (IPH).METHODS:Liver specimens from 29 cases with idiopathic portal hypertension were studied. Histological preparations of the livers were stained with haematoxylin eosin and Masson's trichrome; reticular fibers in the liver tissues were demonstrated. The slides were also stained using some immunohistochemistry methods, and the pathological changes of the livers were analyzed.RESULTS:The characteristic changes found in these IPH livers were dense portal fibrosis; obliteration, with or without phlebitis, of the branches of the portal vein; dilatation of the sinusoids; atrophy and nodular hyperplasia of liver cells.CONCLUSIONS:Histopathological changes of the livers in IPH are dense portal fibrosis, portal vein branch obliteration and nodular hyperplasia of liver cells. These are the main features for a histopathological diagnosis of IPH.
Idiopathic Noncirrhotic Portal Hypertension: An Appraisal

Hwajeong Lee,Aseeb Ur Rehman,M. Isabel Fiel

DOI: https://doi.org/10.4132/jptm.2015.09.23

2016-01-15

Journal of Pathology and Translational Medicine

Abstract:Idiopathic noncirrhotic portal hypertension is a poorly defined clinical condition of unknown etiology. Patients present with signs and symptoms of portal hypertension without evidence of cirrhosis. The disease course appears to be indolent and benign with an overall better outcome than cirrhosis, as long as the complications of portal hypertension are properly managed. This condition has been recognized in different parts of the world in diverse ethnic groups with variable risk factors, resulting in numerous terminologies and lack of standardized diagnostic criteria. Therefore, although the diagnosis of idiopathic noncirrhotic portal hypertension requires clinical exclusion of other conditions that can cause portal hypertension and histopathologic confirmation, this entity is under-recognized clinically as well as pathologically. Recent studies have demonstrated that variable histopathologic entities with different terms likely represent a histologic spectrum of a single entity of which obliterative portal venopathy might be an underlying pathogenesis. This perception calls for standardization of the nomenclature and formulation of widely accepted diagnostic criteria, which will facilitate easier recognition of this disorder and will highlight awareness of this entity.
Symptomatic Hepatic Arterioportal Fistula-Related Portal Vein Hypertension

Tianshi Lyu,Yong Xie,Kang She,Li Song,Yinghua Zou,Jian Wang

DOI: https://doi.org/10.1016/j.jvsv.2024.101888

IF: 4.19

2024-01-01

Journal of Vascular Surgery Venous and Lymphatic Disorders

Abstract:This paper presents the case of a 73-year-old female, consented to the publication of case details and images, who presented with a two-month history of progressively worsening abdominal distension. During hospitalization, she complained of vomiting and pain in the left lower abdomen, and intermittent melena was detected. Abdominal enhanced CT and celiac angiography showed a symptomatic hepatic arterio-portal fistula (HAPF). The schematic diagram (left) showed the location of the HAPF, and the schematic diagram (right) showed the fistula has been embolized and she has undergone shunt surgery (A/Cover, B [redarrow]).
Intrinsic Causes of Nonfibrotic Portal Hypertension—A Clinicopathologic Review of 56 Patients

Hamza Ashmila,Nazia Khatoon,Andrew Keaveny,Muli Krishna,Raouf Nakhleh

DOI: https://doi.org/10.1177/10668969241268406

2024-08-24

International Journal of Surgical Pathology

Abstract:International Journal of Surgical Pathology, Ahead of Print. Aim: The differential diagnosis of intrinsic nonfibrotic conditions that may lead to portal hypertension include hepatoportal sclerosis (HPS), nodular regenerative hyperplasia (NRH), and sinusoidal obstruction syndrome (SOS). In this article, we characterize the clinical features and outcome of these lesions when they manifest as portal hypertension. Methods: Data was collected through retrospective patient medical records. Results: Patients (HPS: 28, NRH: 17, SOS: 11) were identified more frequently in recent years. All groups presented with signs and symptoms of portal hypertension. All patients had complex medical histories. An elevated serum alkaline phosphatase occurred in all groups and an elevated bilirubin with SOS. Imaging of the liver with HPS and NRH suggested cirrhosis, which was not seen with SOS. 11%, 12%, and 9% of patients in the HPS, NRH, and SOS respectively, underwent transjugular intrahepatic portosystemic shunt placement to manage the complications of portal hypertension, while 43%, 24%, and 36% of patients respectively, received a liver transplant. Conclusions: Patients with HPS, NRH, and SOS had complex medical histories, likely contributing to the development of these lesions. They are recognized more frequently now. In contrast to HPS and NRH, SOS occurred in liver transplant recipients, was associated with elevated serum bilirubin, and imaging did not suggest the presence of advanced fibrosis/cirrhosis. Liver transplantation appeared to be a viable treatment for complications related to HPS and NRH. Retransplantation for SOS yielded mixed results. HPS, SOS, and NRH should be considered when evaluating liver specimens from patients with unexplained nonfibrotic portal hypertension. Key message: Intrinsic nonfibrotic causes of portal hypertension appear to be increasing in frequency. The differential diagnosis includes NRH, HPS, and SOS. These conditions are associated with complex diseases and possibly due to treatments. Pathologists need to be aware of this differential diagnosis when presented with liver biopsies performed to assess portal hypertension.

pathology,surgery
Hemodynamic study of portal hypertension

Liu Jianhua,Z. Xuewen,S. Hui,M. Xianmin

2000-01-01

Abstract:null
Current Status of the Clinical Management of Non-Cirrhotic Portal Hypertension

XU Jinghang,YU Yanyan,XU Xiaoyuan

DOI: https://doi.org/10.3969/j.issn.1001-5256.2022.07.001

2022-01-01

Abstract:Non-cirrhotic portal hypertension (NCPH) is not uncommon, and its clinical management strategies are different from those for cirrhotic portal hypertension. According to pathogenesis and etiology, NCPH can be classified into prehepatic, hepatic, and posthepatic NCPH, among which hepatic NCPH can be further classified into presinusoidal, sinusoidal, and postsinusoidal NCPH. Timely diagnosis based on clinical manifestation, radiological examination, and pathology and initiation of corresponding treatment are the key to the clinical management of NCPH. However, the diseases in this group are highly heterogeneous and difficult to diagnose, and it is urgent for clinicians to improve their understanding of such diseases, so as to improve the level of clinical management.
Flow Resistance Analysis of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis.

Yizhe Wang,Luxiang Zhao,Zhuozhao Zheng,Yu Zhang

DOI: https://doi.org/10.1155/2022/9396371

2022-01-01

Canadian Journal of Gastroenterology and Hepatology

Abstract:Cirrhosis-induced clinically significant portal hypertension (CSPH) is a fatal disease. Early detection of CSPH is vitally important to reduce the patients’ mortality rate. In this study, combined with three-dimensional image construction technology and computational fluid dynamics (CFD), an image-based flow resistance analysis was proposed. The flow resistance analysis was performed for nine cirrhosis patients with CSPH and ten participants without liver diseases, respectively. The results showed that the flow resistance coefficient of the portal vein system in CSPH patients was significantly lower than that in the control group (0.97 ± 0.11 Pa/(mL/s) for CSPH patients; 1.80 ± 0.40 Pa/(mL/s) for the control group; P=0.028). In contrast, although main portal vein dilation was found in CSPH patients, the cross-sectional area enlargement was not statistically significant (186.01 ± 57.48 mm2 for CSPH patients; 166.26 ± 33.74 mm2 for the control group; P=0.39). The research outcomes indicated that the flow resistance analysis was more sensitive than the commonly used vessel size measurement in the detection of CSPH. In summary, we suggest using flow resistance analysis as a supplementary noninvasive method to detect cirrhosis patients with CSPH.
Research progress on signaling pathways in cirrhotic portal hypertension

Wen Xu,Ping Liu,Yong-Ping Mu

DOI: https://doi.org/10.12998/wjcc.v6.i10.335

2018-09-26

World Journal of Clinical Cases

Abstract:Portal hypertension (PHT) is an important consequence of liver cirrhosis, which can lead to complications that adversely affect a patient's quality of life and survival, such as upper gastrointestinal bleeding, ascites, and portosystemic encephalopathy. In recent years, advances in molecular biology have led to major discoveries in the pathological processes of PHT, including the signaling pathways that may be involved: PI3K-AKT-mTOR, RhoA/Rho-kinase, JAK2/STAT3, and farnesoid X receptor. However, the pathogenesis of PHT is complex and there are numerous pathways involved. Therefore, the targeting of signaling pathways for medical management is lagging. This article summarizes the progress that has been made in understanding the signaling pathways in PHT, and provides ideas for treatment of the disorder.

medicine, general & internal
Portal Hypertension Induced by Congenital Hepatic Arterioportal Fistula: Report of Four Clinical Cases and Review of the Literature

Dan-Ying Zhang,Shu-Qiang Weng,Ling Dong,Xi-Zhong Shen,Xu-Dong Qu

DOI: https://doi.org/10.3748/wjg.v21.i7.2229

IF: 5.374

2015-01-01

World Journal of Gastroenterology

Abstract:Intrahepatic arterioportal fistula (IAPF) can be caused by many secondary factors. We report four cases of portal hypertension that were eventually determined to be caused by congenital hepatic arterioportal fistula. The clinical manifestations included ascites, variceal hemorrhage and hepatic encephalopathy. Computed tomography scans from all of the patients revealed the early enhancement of the portal branches in the hepatic arterial phase. All patients were diagnosed using digital subtraction angiography (DSA). DSA before embolization revealed an arteriovenous fistula with immediate filling of the portal venous radicles. All four patients were treated with interventional embolization. The four patients remained in good condition throughout follow-up and at the time of publication. IAPF is frequently misdiagnosed due to its rarity; therefore, clinicians should consider IAPF as a potential cause of non-cirrhotic portal hypertension.
Unveiling the impact of cirrhotic cardiomyopathy on portal hemodynamics and survival after transjugular intrahepatic portosystemic shunt: a prospective study

Yaozu Liu,Fangmin Meng,Jingqin Ma,Wen Zhang,Jiaze Yu,Yongjie Zhou,Wuxu Zuo,Zhiping Yan,Cuizhen Pan,Jianjun Luo

DOI: https://doi.org/10.1007/s00261-024-04446-x

IF: 2.4

2024-06-21

Abdominal Radiology

Abstract:The placement of Transjugular intrahepatic portosystemic shunt (TIPS) results in a sudden increase in central circulating blood volume, which requires proper regulation of the cardiovascular system. We aimed to investigate the impact of TIPS on cirrhotic cardiomyopathy (CCM).

radiology, nuclear medicine & medical imaging
Porto-Sinusoidal Vascular Disease: A New Nomenclature Different from Idiopathic Non-Cirrhotic Portal Hypertension

Jie Liu,Qian Zhang,Yao Liu,Hai-Xia Ma,Xu Han,Ying Ma,Li-Li Zhao,Jia Li

DOI: https://doi.org/10.3390/diagnostics14182053

2024-09-16

Abstract:Background and aims: Porto-sinusoidal vascular disease (PSVD) as a novel clinical conception was modified on the basis of idiopathic non-cirrhotic portal hypertension (INCPH). This study aimed to compare the clinical, biochemical histological features and prognosis between the diagnostic criteria for PSVD and that of INCPH. Methods: A total of 65 patients who underwent liver biopsies were analyzed retrospectively. The clinical, pathological and prognosis date were reviewed and screened according to the latest diagnostic criteria of PSVD and INCPH. Results: A total of 65 patients were diagnosed with PSVD, of which 31 (47.69%) also fulfilled INCPH criteria. Specific histological and specific clinical portal hypertension (PH) signs were found in 34 (52.31%) and 30 (46.15%) of the patients, respectively. PSVD patients showed higher LSM levels (11.45 (6.38, 18.08) vs. 7.90 (6.70, 13.00), p = 0.039) than the INCPH patients. INCPH patients had a higher cumulative incidence of liver-related complications than the PSVD patients (86.95% vs. 35.71%, log-rank p < 0.001). Conclusion: Novel PSVD criteria facilitate early diagnosis. PSVD patients with other liver diseases may have higher LSM values. Disease progression and survival outcomes are correlated with PH in PSVD patients.
Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI

Ji Hun Kang,Do Hyung Kim,So Yeon Kim,Hyo Jeong Kang,Jung Bok Lee,Kyoung Won Kim,Seung Soo Lee,Jonggi Choi,Young-Suk Lim

DOI: https://doi.org/10.1007/s00261-020-02831-w

Abstract:Purpose: To differentiate the computed tomography (CT) and magnetic resonance imaging (MRI) features of porto-sinusoidal vascular disease (PSVD) and liver cirrhosis (LC). Methods: In this retrospective case-control study of patients with PSVD matched in a 1:3 ratio with LC patients according to liver function, initial diagnosis and time to final diagnosis were analyzed. Imaging features on CT and the parenchymal enhancement on hepatobiliary phase of hepatobiliary agent-enhanced MRI (HBA-MRI) were compared using a generalized linear mixed model. Focal hepatic lesions in the PSVD group were analyzed. Results: In total, 43 PSVD patients and 129 LC patients were included. Among PSVD patients, 72.1% were initially misdiagnosed with LC. PSVD patients had a longer diagnostic delay than LC patients (32 months vs. 4 months; p < 0.001). Liver surface nodularity was less common in the PSVD group than in the LC group (16.3% vs. 89.2%, p < 0.001). Increased caudate-to-right lobe ratio, heterogeneous parenchymal enhancement, and portal vein abnormalities were more frequently noted in the PSVD group than in the LC group (all p < 0.001). The grade of portal hypertension was significantly higher in the PSVD group than in the LC group (p < 0.001), and they also had brighter parenchymal enhancement during the hepatobiliary phase of HBA-MRI (p < 0.001). In the PSVD group, 14% patients had at least one focal hepatic lesion, primarily a focal nodular hyperplasia (FNH)-like nodule. Conclusions: Some imaging features on CT and HBA-MRI can distinguish PSVD from LC. Benign focal lesions, most commonly FNH-like nodules, can develop in PSVD.
[Progress in the Research on Hemodynamics of Portal Hypertension].

Fang Shen,Zongyi Yan,Weiguang Zhang

DOI: https://doi.org/10.3321/j.issn:1001-5515.2003.02.038

2003-01-01

Abstract:Portal hypertension (PHT), as a disease with high incidence all over the world, badly affects the patients' health. The research on hemodynamics plays an important role in exploring the pathogenesis of PHT, assessing the risk of hemorrhage induced by the complications, selecting the scheme and time of surgical operations as well as evaluating the curative effects of medication. In this article, the main factors in the pathogeny of PHT are reviewed and the surgical treatments are discussed from the hemodynamic viewpoint. Then some recent results in the hemodynamic research of PHT are summarized. In addition, main ideas are put forward as to establishing a new global biomechanical model of PHT.
Diagnostic Methods for Cirrhosis and Portal Hypertension

DOI: https://doi.org/10.1007/978-3-319-72628-1

2018-01-01

Abstract:This book provides a unique up-to-date and comprehensive overview of the most important diagnostic methods available for assessing liver cirrhosis and portal hypertension. The book covers all the significant advances made in the last 10 years in HVPG and biopsy interpretation, imaging and elastography. This is a unique and well structured book authored by senior experts in the field aimed at providing updated knowledge to the hepatology specialist and to the physicians interested in chronic liver disease. The book starts by giving an overview of the disease, outlining the clinical needs in this field; this is followed by detailed information both on the invasive gold-standard methods (HVPG measurement, liver biopsy, endoscopy), and on the standard and emerging non-invasive methods, including serum markers of fibrosis, ultrasound-elastography, magnetic resonance elastography, ultrasound, contrast-enhanced ultrasound, CT, magnetic resonance and derived methods (dynamic flow assessment). The final part of the book is devoted to diagnostic tests in non-cirrhotic causes of portal hypertension (Budd-Chiari Syndrome, Portal vein thrombosis, idiopathic portal hypertension, etc), and in pediatric portal hypertension. Written by a team of worldwide opinion leaders this book pays special attention to the most promising novel non-invasive methods in the field.
Application of liver biopsy in etiological diagnosis of unexplained portal hypertension: Porto-sinusoidal vascular disease should not be ignored

Yu Zhang,Hongli Liu,Qingfang Xiong,Yandan Zhong,Duxian Liu,Wei Chen,Yongfeng Yang

DOI: https://doi.org/10.1097/md.0000000000039819

IF: 1.6

2024-09-29

Medicine

Abstract:Portal hypertension (PH) is a common and serious clinical syndrome characterized by hemodynamic abnormalities of the portal venous system. Esophagogastric variceal bleeding, hepatic encephalopathy, and ascites are serious complications of PH that often result in liver transplantation or death. [ 1 ] Liver cirrhosis is the leading cause of portal hypertension and end-stage chronic liver disease. Alcoholic steatohepatitis is the leading cause of cirrhosis in western countries and India, whereas chronic hepatitis B and C are the main causes of cirrhosis in Asia. Non-cirrhotic portal hypertension (NCPH) accounts for approximately 10% to 20% of portal hypertension. [ 2 ] Porto-sinusoidal vascular disease (PSVD) and extrahepatic portal vein thrombosis are the most common etiologies of NCPH and are characterized by obvious symptoms of portal hypertension, but almost normal liver function. [ 3 , 4 ]

medicine, general & internal
Regression of portal hypertension: underlying mechanisms and therapeutic strategies

Sonia Selicean,Cong Wang,Sergi Guixé-Muntet,Horia Stefanescu,Norifumi Kawada,Jordi Gracia-Sancho

DOI: https://doi.org/10.1007/s12072-021-10135-4

IF: 9.029

2021-02-01

Hepatology International

Abstract:Abstract Portal hypertension is the main non-neoplastic complication of chronic liver disease, being the cause of important life-threatening events including the development of ascites or variceal bleeding. The primary factor in the development of portal hypertension is a pathological increase in the intrahepatic vascular resistance, due to liver microcirculatory dysfunction, which is subsequently aggravated by extra-hepatic vascular disturbances including elevation of portal blood inflow. Evidence from pre-clinical models of cirrhosis has demonstrated that portal hypertension and chronic liver disease can be reversible if the injurious etiological agent is removed and can be further promoted using pharmacological therapy. These important observations have been partially demonstrated in clinical studies. This paper aims at providing an updated review of the currently available data regarding spontaneous and drug-promoted regression of portal hypertension, paying special attention to the clinical evidence. It also considers pathophysiological caveats that highlight the need for caution in establishing a new dogma that human chronic liver disease and portal hypertension is reversible.

gastroenterology & hepatology
Label-free characterization of pathological changes in the portal area of liver fibrosis tissue using multiphoton imaging and quantitative image analysis

Xiong Zhang,Yuan-E Lian,XunBin Yu,XingXin Huang,Zheng Zhang,Jingyi Zhang,Jianxin Chen,Lianhuang Li,Yannan Bai

DOI: https://doi.org/10.1088/1361-6463/ad73e6

2024-08-29

Journal of Physics D Applied Physics

Abstract:Liver fibrosis plays a crucial role in the progression of liver diseases and serves as a pivotal stage leading to the development of liver cirrhosis and cancer. It typically initiates from portal area with various pathological characteristics. In this article, we employed multiphoton microscopy (MPM) to characterize the pathological changes in the portal areas of liver fibrosis tissues, and subsequently, we used our developed image analysis method to extract eight collagen morphological features from MPM images and also combined a deep learning method with a cell nuclear feature extraction algorithm to perform automatic nuclei segmentation and quantitative analysis in the H&E-stained histopathology images of portal areas. Our results demonstrate that MPM can effectively identify various pathological features in portal areas, and there are significant differences in four collagen features (collagen proportionate area, number, length and width) between normal and abnormal portal areas and in four nuclear features (mean axes distance ratio, disorder of distance to 3, 5 and 7 nearest neighbors) between normal portal area, bile duct hyperplasia and periductal fibrosis. Therefore, a combination of MPM and image-based quantitative analysis may be considered as a rapid and effective means to monitor histopathological changes in portal area and offer new insights into liver fibrosis.

physics, applied
Histopathological features of idiopathic portal hypertension: A systematic review and meta-analysis

Adnan Malik,Sohira Malik,Ahsan Farooq,Muhammad Imran Malik,Sadia Javaid

DOI: https://doi.org/10.1177/00368504241264996

Abstract:Background: Portal hypertension (PH) is a clinically significant entity that could present with life-threatening gastrointestinal bleeding. Cirrhosis is the most common cause of PH, with well-documented histopathology and etiology. However, in idiopathic portal hypertension (IPH), no single histopathologic finding is associated with PH. Our systematic review aims to identify and summarize the prevalence of the common histological findings of IPH. Methods: We systematically searched PubMed, Cochrane CENTRAL, Web of Science, and Scopus till 1ST March 2022 for studies describing the histopathological features of IPH. Data were extracted from eligible studies and pooled as events rate and 95% confidence interval (CI) using binary random-effects model by open meta-analyst software. Results: We included 23 retrospective studies with a total sample size of 813 patients. The overall incidence of nodular regenerative hyperplasia was 38.6%, 59.8% for portal fibrosis, 51.3% for periportal fibrosis, 39.3% for perisinusoidal fibrosis, 89.8% for portal vein sclerosis, 42.2% for portal inflammation, 53.3% for mega-sinusoids, 39.5% for thickening of portal vein branches, 93.8% for narrowing of portal veins, 53.3% for hepatic veins/venous outflow obstruction, 51.4% for aberrant portal/periportal vessels, 42.4% for shunt vessel, 50.9% for ductular proliferation, and 16.3% for steatosis. Conclusion: Due to the relatively non-pathognomonic and non-specific nature of IPH, a combination of different histological features such as the portal and periportal fibrosis, portal vein sclerosis, mega-sinusoids, narrowing of portal veins, hepatic venous outflow obstruction, aberrant portal or periportal vessels, and ductular proliferation may be of value in diagnosing IPH as the incidence rate of these features was at approximately 50%.
Updates in the Research of Portal Vein Thrombosis in Patients with Cirrhosis and Portal Hypertension after Splenectomy

Liu Xirui,Liu Lianxin

DOI: https://doi.org/10.3760/cma.j.issn.1673-9752.2015.02.020

2015-01-01

Abstract:Portal vein thrombosis (PVT) is a severe complication in patients with cirrhosis and portal hypertension after splenectomy.PVT can aggravate liver damage,ischaemic intestinal necrosis and gastrointestinal bleeding.In recent years,numerous studies have been published on the risk factors,diagnosis,prevention and treatment of PVT.Imaging examination in patients could be done for early diagnosis of PVT and improve the prognosis of patients.

Imaging and Pathological Features of Idiopathic Portal Hypertension and Differential Diagnosis from Liver Cirrhosis

Treatment Options for Portal Hypertension in the Era of Liver Transplantation

Liver Pathology in Idiopathic Portal Hypertension

Idiopathic Noncirrhotic Portal Hypertension: An Appraisal

Symptomatic Hepatic Arterioportal Fistula-Related Portal Vein Hypertension

Intrinsic Causes of Nonfibrotic Portal Hypertension—A Clinicopathologic Review of 56 Patients

Hemodynamic study of portal hypertension

Current Status of the Clinical Management of Non-Cirrhotic Portal Hypertension

Flow Resistance Analysis of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis.

Research progress on signaling pathways in cirrhotic portal hypertension

Portal Hypertension Induced by Congenital Hepatic Arterioportal Fistula: Report of Four Clinical Cases and Review of the Literature

Unveiling the impact of cirrhotic cardiomyopathy on portal hemodynamics and survival after transjugular intrahepatic portosystemic shunt: a prospective study

Porto-Sinusoidal Vascular Disease: A New Nomenclature Different from Idiopathic Non-Cirrhotic Portal Hypertension

Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI

[Progress in the Research on Hemodynamics of Portal Hypertension].

Diagnostic Methods for Cirrhosis and Portal Hypertension

Application of liver biopsy in etiological diagnosis of unexplained portal hypertension: Porto-sinusoidal vascular disease should not be ignored

Regression of portal hypertension: underlying mechanisms and therapeutic strategies

Label-free characterization of pathological changes in the portal area of liver fibrosis tissue using multiphoton imaging and quantitative image analysis

Histopathological features of idiopathic portal hypertension: A systematic review and meta-analysis

Updates in the Research of Portal Vein Thrombosis in Patients with Cirrhosis and Portal Hypertension after Splenectomy